Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.


Player Avatar pchop123 (80.22) Submitted: 2/23/2013 12:40:08 PM : Outperform Start Price: $161.51 REGN Score: +6.57

I am willing to consider the promise of this biotech at this lower buyin point now

Featured Broker Partners